Boston University School of Medicine, Boston, Massachusetts 02118, USA.
Ann Intern Med. 2011 Aug 2;155(3):137-44. doi: 10.7326/0003-4819-155-3-201108020-00003.
Because pulmonary nodules are found in up to 25% of patients undergoing computed tomography of the chest, the question of whether to perform biopsy is becoming increasingly common. Data on complications after transthoracic needle lung biopsy are limited to case series from selected institutions.
To determine population-based estimates of risks for complications after transthoracic needle biopsy of a pulmonary nodule.
Cross-sectional analysis.
The 2006 State Ambulatory Surgery Databases and State Inpatient Databases for California, Florida, Michigan, and New York from the Healthcare Cost and Utilization Project.
15 865 adults who had transthoracic needle biopsy of a pulmonary nodule.
Percentage of biopsies complicated by hemorrhage, any pneumothorax, or pneumothorax requiring a chest tube, and adjusted odds ratios for these complications associated with various biopsy characteristics, calculated by using multivariate, population-averaged generalized estimating equations.
Although hemorrhage was rare, complicating 1.0% (95% CI, 0.9% to 1.2%) of biopsies, 17.8% (CI, 11.8% to 23.8%) of patients with hemorrhage required a blood transfusion. In contrast, the risk for any pneumothorax was 15.0% (CI, 14.0% to 16.0%), and 6.6% (CI, 6.0% to 7.2%) of all biopsies resulted in pneumothorax requiring a chest tube. Compared with patients without complications, those who experienced hemorrhage or pneumothorax requiring a chest tube had longer lengths of stay (P < 0.001) and were more likely to develop respiratory failure requiring mechanical ventilation (P = 0.020). Patients aged 60 to 69 years (as opposed to younger or older patients), smokers, and those with chronic obstructive pulmonary disease had higher risk for complications.
Estimated risks may be inaccurate if coding of complications is incomplete. The analyzed databases contain little clinical detail (such as information on nodule characteristics or biopsy pathology) and cannot indicate whether performing the biopsy produced useful information.
Whereas hemorrhage is an infrequent complication of transthoracic needle lung biopsy, pneumothorax is common and often necessitates chest tube placement. These population-based data should help patients and physicians make more informed choices about whether to perform biopsy of a pulmonary nodule.
Department of Veterans Affairs and National Cancer Institute.
在接受胸部计算机断层扫描的患者中,高达 25%的患者发现了肺部结节,因此关于是否进行活检的问题变得越来越普遍。关于经胸针吸肺活检后并发症的数据仅限于来自选定机构的病例系列。
确定人群中经胸针吸肺活检后发生并发症的风险估计值。
横断面分析。
来自医疗保健成本和利用项目的加利福尼亚州、佛罗里达州、密歇根州和纽约州的 2006 年州门诊手术数据库和州住院患者数据库。
15865 名成年人接受了经胸针吸肺活检。
出血、任何气胸或需要胸腔引流管的气胸的活检并发症百分比,以及使用多变量、人群平均广义估计方程计算的与各种活检特征相关的这些并发症的调整后优势比。
尽管出血很少见,仅占活检的 1.0%(95%CI,0.9%至 1.2%),但有 17.8%(CI,11.8%至 23.8%)的出血患者需要输血。相比之下,所有活检中气胸的风险为 15.0%(CI,14.0%至 16.0%),有 6.6%(CI,6.0%至 7.2%)的活检导致需要胸腔引流管的气胸。与无并发症的患者相比,经历出血或需要胸腔引流管的气胸的患者住院时间更长(P <0.001),更有可能发生需要机械通气的呼吸衰竭(P =0.020)。60 至 69 岁的患者(与年龄较小或较大的患者相比)、吸烟者和患有慢性阻塞性肺疾病的患者并发症风险更高。
如果并发症的编码不完整,估计的风险可能不准确。分析的数据库包含很少的临床细节(例如结节特征或活检病理学信息),并且无法表明进行活检是否产生了有用的信息。
虽然经胸针吸肺活检后出血是一种罕见的并发症,但气胸很常见,通常需要放置胸腔引流管。这些基于人群的数据应帮助患者和医生更明智地选择是否对肺部结节进行活检。
退伍军人事务部和国家癌症研究所。